NIH-funded research R21 grant

Investigating the role of skin fungi in health and disease

Official title: Malassezia and Candida auris: skin microbiome dysbiosis and de-regulation of cutaneous homeostasis

Funded at Duke University · NIH-10771278 · Data updated 2026-11-12

This study is looking at how certain types of fungi on our skin can impact our health, especially when they get out of balance, and it aims to find new ways to help treat skin conditions and infections that might affect you.

More Dysbiosis research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startFebruary 1, 2023
Project endJanuary 31, 2026
Funding year2024
Award (this year)$174,750
NIH project number5R21AI168672-02
Project IDNIH-10771278 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with skin diseases or those at risk for infections related to Malassezia or Candida auris.

Less likely to help

Patients who do not have skin conditions or are not at risk for fungal infections may not receive direct benefits from this research.

What this research studies

This research explores how certain fungi, specifically Malassezia and Candida auris, affect skin health and disease. It examines the balance of these fungi in the skin microbiome and how disruptions can lead to infections and other health issues. By using advanced genetic techniques, the study aims to understand the interactions between these fungi and the immune system, potentially leading to new insights into skin-related conditions and systemic infections. Patients may benefit from findings that could improve treatment strategies for skin diseases and infections.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for skin infections and better management of conditions linked to skin microbiome imbalances.

How similar studies have gone: Previous research has shown promising results in understanding the role of skin microbiomes in health, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Heitman, Joseph — Duke University
  • Study coordinator: Heitman, Joseph

Related research

Other NIH-funded projects on the same topics.

  • Microbial Dysbiosis and Its Role in Pancreatic Cancer

    A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.

    NIH research Northwestern University · Chicago, United States · NIH-11624054

  • From Symbiosis to Dysbiosis: How Resolving Inflammation Could Restore Your Mouth’s Balance

    This grant explores how turning off the harmful inflammation in periodontitis and promoting natural healing could help restore the mouth’s healthy balance.

    NIH research Ada Forsyth Institute, INC. · Somerville, UNITED STATES · NIH-11621747

  • Antibiotics, gut health, and skin reactions in kids

    A small study in children will look at whether antibiotic use and gut bacteria play a role in hives and related symptoms that children sometimes get after antibiotics.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11603169

  • Novel therapeutic to protect the gut after radiation

    A new GI-directed treatment given after radiation exposure may reduce gut damage and improve survival in people exposed to high-dose radiation.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572662

  • A new GI-focused treatment to reduce radiation damage after exposure

    A potential GI-targeted therapy given after radiation exposure may help protect the gut and improve survival in people affected by radiation injuries.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572658

  • How a mouth bacterium might fuel gum disease and heart risk

    A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11564245

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.